(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CLNC

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CLNC

ST13

US500000075338003

Class

-

Filing

75338003

Registration

2409723

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

42

Latest update

03/23/2021

Trademark type

Word

Nice classes

-

Filing date

08/08/1997

Registration date

12/05/2000

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/23/2021

Last transaction

03/23/2021

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Drawing code

1

Owner type

03

Owner location

Houston, TX, US

Examiner

LEVY,MICHAEL S

Law office

M10

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

MEDICAL-LEGAL CONSULTING INSTITUTE, INC.

Representatives

Constance Gall Rhebergen BRACEWELL LLP

Technical classification

Nice Classes

No classes reported.

Vienna Codes

No Vienna codes available.

Goods and services

No goods and services specifications.

Publications

History of USPTO decisions and trademark events.

42 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

03/23/2021

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

03/23/2021

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

03/23/2021

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

03/22/2021

PR89

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

09/24/2020

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

09/21/2020

PR89

POST REGISTRATION ACTION MAILED - SEC. 8 & 9

08/28/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/20/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/17/2020

E89R

TEAS SECTION 8 & 9 RECEIVED

06/30/2020

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

12/05/2019

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/07/2018

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/07/2018

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

02/19/2010

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

02/19/2010

E89R

TEAS SECTION 8 & 9 RECEIVED

02/12/2010

15AK

REGISTERED - SEC. 15 ACKNOWLEDGED

12/07/2007

PLGL

ASSIGNED TO PARALEGAL

11/28/2007

E15R

TEAS SECTION 15 RECEIVED

11/23/2007

CFIT

CASE FILE IN TICRS

07/28/2006

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

07/25/2006

PLGL

ASSIGNED TO PARALEGAL

07/20/2006

CCON

COUNTERCLAIM OPP. NO. 999999

05/11/2006

8.AF

REGISTERED - SEC. 8 (6-YR) FILED

04/25/2006

ES8R

TEAS SECTION 8 RECEIVED

04/25/2006

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/22/2006

R.PR

REGISTERED-PRINCIPAL REGISTER

12/05/2000

PUBO

PUBLISHED FOR OPPOSITION

09/12/2000

NPUB

NOTICE OF PUBLICATION

08/11/2000

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/26/2000

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/22/2000

CNRT

NON-FINAL ACTION MAILED

04/03/2000

DOCK

ASSIGNED TO EXAMINER

02/10/2000

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

02/10/2000

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/06/2000

DOCK

ASSIGNED TO EXAMINER

01/05/2000

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/29/1999

CNRT

NON-FINAL ACTION MAILED

10/25/1999

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/13/1998

CNRT

NON-FINAL ACTION MAILED

04/07/1998

DOCK

ASSIGNED TO EXAMINER

04/01/1998

DOCK

ASSIGNED TO EXAMINER

03/20/1998

Continuous trademark protection

Get notified about every new filing that threatens CLNC or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.